| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Sep 13, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that Mori Arkin, Vice Chairman and General Manager, Perrigo Global Generics and API, has advised the Company that he will retire at the...
-
Aug 23, 2007* Full year revenue increased 6 percent to $1.45 billion; earnings per share increased 4 percent to $0.79, and rose 7 percent to $0.89 on a non-GAAP basis
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for fiscal year 2007 and the fourth quarter ended June 30, 2007. Perrigo Company (in thousands, except per share amounts) Fourth...
-
Aug 16, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.045 per share, payable on September 18, 2007 to shareholders of...
-
Aug 9, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its fiscal year 2007 on Thursday, August 23, 2007 at approximately 8:00 a.m. (ET). The Company...
-
Jul 11, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has closed its transaction to acquire Qualis, Inc., a privately-owned manufacturer of store brand pediculicide products for...
-
Jun 20, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that the U.S. Food & Drug Administration (FDA) has granted tentative approval to Dexcel Pharma Technologies, Ltd. (Dexcel) for its...
-
Jun 7, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph C. Papa, Perrigo's President and CEO will present at the Goldman Sachs Twenty-Eighth Annual Global Healthcare Conference on...
-
Jun 6, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that a federal court has ruled in its favor in patent litigation involving Famotidine Complete. Perrigo had been sued by Johnson &...
-
May 30, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market over-the-counter coated nicotine polacrilex...
-
May 8, 2007Third Quarter Sales $362 million, up 9%
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the third quarter of fiscal year 2007 ended March 31, 2007. Perrigo Company (in thousands, except per share amounts)...
-
May 2, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that its Board of Directors declared a quarterly dividend of $0.045 per share, payable on June 19, 2007 to shareholders of record on...
-
May 1, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the Morgan Stanley Global Healthcare Unplugged Conference on Thursday, May...
-
Apr 27, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its third quarter fiscal 2007 on Tuesday, May 8, 2007 at approximately 8:00 a.m. (ET). The...
-
Apr 5, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the CIBC World Markets Biotechnology & Pharmaceuticals Conference on...
-
Mar 27, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced an organizational restructuring to further enhance the management of the Company's global operations. John Hendrickson has been named...
-
Mar 7, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has entered into a purchase agreement to acquire Qualis, Inc., a privately-owned manufacturer of store brand pediculicide...
-
Mar 6, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the Citigroup Small & Mid-Cap Conference on Tuesday, March 13, at 10:45...
-
Feb 22, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced the appointment by the Board of Directors of Ben-Zion Zilberfarb as a new director of the Company. Dr. Zilberfarb was appointed to...
-
Feb 8, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that the Board of Directors has authorized the repurchase of $60 million of the Company's common stock through February 8, 2009 under...
-
Feb 1, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical...
-
Feb 1, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced results for the second quarter of fiscal year 2007 ended December 30, 2006. Perrigo Company (in thousands, except per share amounts)...
-
Jan 18, 2007
Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it will release financial results for its second quarter fiscal 2007 on Thursday, Feb. 1, 2007 at approximately 7:30 a.m. (ET). The...
-
Jan 4, 2007
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) announced today that Joseph Papa, Perrigo's President and CEO will present at the 25th Annual JPMorgan Healthcare Conference on Thursday, January 11,...
-
Dec 21, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to market Simvastatin Tablets, USP, 5 mg, 10 mg, 20...
-
Dec 19, 2006
The Perrigo Company (NASDAQ: PRGO)(TASE: PRGO) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) to manufacture and market Ciclopirox Topical...